Hello, everyone, and how are you today? We are as busy as can be. As usual, we are hustling the short people off to the local school houses and preparing for our webinar today on how pharma can manage the unmanageable media with former CNBC reporter and PR man Mike Huckman (see this). So no need for further delay. Here are some tidbits to help us all get started. Have a great day and stay in touch...
France Halts Reimbursement For Sanofi's Multaq (Reuters)
Pfizer's Prevnar 13 Wins FDA Panel Backing For Older Adults (Bloomberg News)
J&J Starts Removing Toxins From Baby Products (Associated Press)
Bayer Sells Indiana Facility And 270 Workers May Lose Jobs (WNDU)
Incyte Gets First FDA OK For Rare Blood Cancer Drug (Pharma Times)
GAVI Agrees To Fund HPV Vaccines In Poor Nations (Reuters)
UK's NICE Rejects Eisai's Halaven Breast Cancer Med (Pharma Times)
China Fines Two Middleman For Cornering Market On A Drug (Reuters)
India To End Price Controls For Bulk Drugs (InPharma Technologist)
Large Russian Distributor Goes Bankrupt (RAPSI)
Lupin Acquires Japanese Injectable Maker (India Info Online)
EDITOR'S NOTE: Please check this post for updates throughout the morning